table network network 2
demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only observational study
COVID-19 severe or critically
COVID-19 (hospitalized or not)
anti-inflammatoty and immuno-therapy
anti-inflammatory therapies Esba
colchicine Manenti
non-steroidal anti-inflammatory drugs Park Kragholm Abu Esba LC ... Gianfransesco Lund
Ibuprofen Rinott
corticosteroids Husain Wu
Immunostimulants drugs
levamisole Roostaei
neutralizing antibody
casirivimab/imdevimab (Ronapreve) Wei
Immunosuppressants drugs
anti-interleukin-6
tocilizumab Hong Zhao
statins Zhang

0 studies excluded by filtering options 2

 

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons